Brahman Capital’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Brahman Capital's TEVA Position: Q3 2020 in Review
Brahman Capital sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2020, closing a stake of 1,303,003 shares — an estimated $16.1M sold.
Brahman Capital first reported a position in TEVA in Q4 2017 and held it in 9 quarters. The position peaked at $258M in Q2 2018. 445 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.
- Brahman Capital reported no remaining Teva Pharmaceutical Industries position as of Q3 2020 after selling out during the quarter.
- Brahman Capital sold 1,303,003 Teva Pharmaceutical Industries shares in Q3 2020, an estimated $16.1M.
- Brahman Capital first reported a position in Teva Pharmaceutical Industries in Q4 2017 and held it in 9 quarters.
- Brahman Capital's Teva Pharmaceutical Industries position peaked at $258M in Q2 2018.
- 445 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2020.
Based on Brahman Capital's 13F filing for Q3 2020, filed 16 Nov 2020.